BRAND_ANALYSIS #BIONTECH HEALTH & PHARMA #25 OF 26 IN HEALTH & PHARMA ALIGNED

BioNTech

· Public · Updated 22 Nov 2026 07:19 UTC
#1112 of 1208 overall by tension · #25 of 26 in Health & Pharma
6 Aligned
The Balanced
Analysis

BioNTech posts C40 / B34 / T6 with a 9.71 percent stock fall, the weakest business score in the batch after Lucid. The vaccine pioneer has lost both cultural momentum and commercial traction. Its pandemic fame is fading faster than its pipeline can replace it.

IN THE NEWS (35 articles this week)
BioNTech SE (BNTX) stock price, news, quote and history - Yahoo Finance UK
Moderna vs. BioNTech: Why Only 1 Is a Buy Heading Into 2027 - The Motley Fool
BioNTech SE (BNTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cultural Score
40 / 100
Business Score
34 / 100
TENSION▁▁▃▃▂▂▁▁▂▁▂▁▁▁
CULTURAL▅▄▄▄▄▄▄▄▄▃▄▄▄▃
BUSINESS▄▃▂▂▂▃▃▃▃▃▃▃▃▃
Loading...
Wikipedia Momentum 15/40
News Presence 26/35
Search InterestRedistributed to other dimensions
Stock Momentum 12/30
Market Position 16/25
Revenue Growth 3/25
Earnings Health 3/20
Price$80.96
30d Change-9.7%
Market Cap$20.1B
Profit Margin-60.9%
BioNTech's tension is 6. Culture outpacing commerce. sociologyofcapitalism.com/brand/biontech
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/biontech.html" width="320" height="200" frameborder="0"></iframe>